⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Class Action Reminder from Pomerantz LLP for Shareholders of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Join Class Action to Recover Losses from ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Securities Class Action: Rosen Law Firm Encourages Investors With Losses in Excess of $100K to Secure Counsel Before Important October 5 Lead Plaintiff Deadline
accessnewswire.com
SPRY
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join by October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
SPRY
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY
prnewswire.com
SPRY
October 5, 2026 Deadline: Join Class Action Lawsuit Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
Class Action Reminder from Pomerantz LLP for Shareholders of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY